2008-06-23 23:48:08 -

www.celsion.com - CELSION CORPORATION (NASDAQ: CLN) announced today the change of its NASDAQ stock ticker symbol from CLN to CLSN. The new ticker symbol will go into effect at the start of trading on June 30, 2008.

"We are pleased to announce our new ticker symbol, one that we believe will improve our visibility with investors and more closely associate our company with the NASDAQ on which our shares have traded since February 2008," said Michael H. Tardugno, President and Chief Executive Officer of Celsion. "We continue to successfully execute on our strategy and our focus remains on building value for all shareholders."

About Celsion

Celsion is dedicated to the development and commercialization of oncology drugs including

tumor-targeting treatments using focused heat energy in combination with heat-activated drug delivery systems. Celsion has research, license or commercialization agreements with leading institutions such as the National Institutes of Health, Duke University Medical Center, University of Hong Kong, Cleveland Clinic and the North Shore Long Island Jewish Health System. For more information on Celsion, visit our website: www.celsion.com. (CLN-W)

Cameron Associates
Paul G. Henning, 212-554-5462
phenning@cameronassoc.com